
Keywords: P-glycoprotein; MDR-1; MDR modulators; Chemosensitizers; Anticancer; Drug designABC, ATP-binding cassette; ATP, adenosine-5′-triphosphate; Bcl-2, B-cell lymphoma-2; CDKs, cycline-dependent kinases; DBP, drug-binding pocket; DXR, doxorubicin; IAPs, inhibit